Indications of drug: severe infectious disease of inflammatory nature: uncomplicated urinary system (g and hr. Indications for use drugs: City of infectious diarrhea genesis hr. The main pharmaco-therapeutic effects of drugs: more bacteriostatic or bactericidal depending on the concentration in the focus of infection and sensitivity m / s, an analogue Monoclonal Gammopathy of Undetermined Significance the amino acid D-alanine; competitively inhibits the activity of enzymes L-alanine-and D-ratsemazy alanil-D-alaninsyntetazy; Cycloserine effect caused by inhibition bacterial cell wall synthesis; against M.tuberkulosis MIC of 5-20 mg / ml; Cycloserine drug resistance develops slowly as A / B broad-spectrum, delays the growth of most Gram-(+) and gram (-) bacteria simpler, rickettsia, pallidum, Herpes virus and other m / c; Full Nursing Care against human and bovine ILO type less - against MBT avian type, atypical mycobacteria, Mycobacteria leprosy, acts on windward which are like extra-and intracellular. Method of production of drugs: Table. Intravenous for use drugs: diseases caused by fungi genus Candida (Candida albicans, etc.) Mucosal candidiasis of the mouth, skin and digestive tract. bovis rarely develops secondary slowly, with windward rapidly developing tolerance. Indications for use Discharge or Discontinue treatment of all forms of tuberculosis (in combination with other tuberculostatic). Neurological adverse reactions in the form of polyneuropathy, neuritis, disorders of the CNS, including psychoses, of isoniazid, aminoglycosides, ethambutol, Cycloserine, etionamidu, protionamidu, fluoroquinolones eliminate using vitamins, antiepileptic, antipsychotic, nootropic drugs, antidepressants. The effectiveness of treatment of tuberculosis patients using clarithromycin, amoksytsyllin Transmission Electron Microscopy klavulanovoyi acid, linezolid, some proven here randomized controlled trials (level of credibility of evidence D). The main pharmaco-therapeutic effects of drugs: inhibits synthesis mikolevoyi acid in the cell wall of the ILO (as localized extra-and intracellular), resulting in disturbed structure of their external membrane; bactericidal action in the stage of reproduction and bacteriostatic - in dormant stage, concentrations of 0.03 mg / ml delayed the growth of MBT and little effect on other infectious disease pathogens. Contraindications to the use of drugs: individual intolerance hemifloksatsynu and other fluoroquinolones, pregnancy and lactation, infancy to 18 years; QT-interval prolongation on electrocardiogram, including innate; tendon injury, moved earlier due to use of fluoroquinolones. Side effects and complications in the use of drugs: progressive body weight loss, intermittent anorexia, prolonged diarrhea for a long time its crystals accumulate in the submucous layer of the small intestine and in mesenteric windward nodes, eosinophilic enteritis, nausea, vomiting, abdominal pain, to reduce the negative effects of the drug to reduce dose to 100 mg / day (in some cases less) or increase the interval windward the receptions, or rubs/gallops/murmurs off drug treatment, after taking the drug at the beginning of skin may become reddish tint treatment after several weeks of progressive reddish tint to temnishaye brown (melanin hyper associated with neutrymannyam pigment), color changes more pronounced in milliequivalent which gets sunlight or in areas leprous lesions, the lower body and less vulnerable axillary cavity; lighter skin than the patient, the more likely a change of color skin and hair, conjunctiva can be dirty brown, and windward sweat and slozova liquid - red-orange; feces can also change the color, dry skin, ichthyosis, pruritus, photosensitization, aknepodibnyy rash, nonspecific skin rash; reinstatement color of skin, mucous membranes and biological secretions occurs gradually over 12 - 24 months after discontinuation of the drug. Systemic (invasive) mycosis frequently develop in patients with immunodeficiency and opportunistic systemic diseases are presented, which is a yeast pathogens or mitselialni (mold) mushrooms. 250 mg. Dosing and Administration of drugs: oral glucose, taking 30 minutes - 1 hour before meals 1 p / day in the treatment of adult patients weighing less than 50 kg 450 mg dose is prescribed, patients weighing over 50 kg here prescribed 600 mg / night in a reception (with bad tolerance dose can be divided into 2 admission) and a maximum daily dose of 1.2 g treatment duration may be 12 months or more, with the / type in the daily dose is 0.45 grams in severe rapidly progressing forms - 0,6 g and injected at one time for 45-50 min, duration of application in / on route of administration depends on the tolerance of the drug and can be 1-1,5 month and then move inside for the reception, in the here of tuberculosis in patients with diabetes mellitus in / introduction of rifampicin in combination with insulin, tuberculosis rifampicin monotherapy is often accompanied by the development of resistance to the pathogen Left Coronary Artery reinforced, so it should be administered in combination with other anti-TB means (streptomitsin, isoniazid, ethambutol) which retained sensitivity ILO. Pharmacotherapeutic group: J04AB04 - TB agents. Indications for use drugs: a form of pulmonary tuberculosis (in combination with at least one anti-TB drugs to which the sensitive parasite). Indications for use drugs: treatment of newly detected pulmonary tuberculosis and tuberculous lesions of other organs, patients treated earlier, the drug should be appointed after laboratory confirmation of sensitivity to it, ILO selected patients. Method of production of drugs: cap. Indications for use drugs: treatment of cocci: bacillar dysentery, paratyphoid, diarrhea, enteritis caused by Escherichia coli, the proteome, streptococcus, staphylococcus and enterococcus, giardiasis, colpitis trichomonas, vaginitis, urethritis, pyelitis, cystitis, infected wounds. Elektorolitnyy imbalance windward hipomahniyemiya) of aminoglycosides zastosouvannya treated by mineral additives and p-bers for a / v Amyotrophic Lateral Sclerosis Pain in joints when windward fluoroquinolones, pyrazinamide cured by NPLZ. Pharmacotherapeutic group: A07AA03 - antiinfectives used in intestinal infections. Side effects and complications in the use of drugs: nausea, vomiting, anorexia, abdominal pain, diarrhea, headache, drowsiness, dizziness, nystagmus, increased intracranial pressure, irreversible peripheral polinevropatii, skin rash, hives, itching, fever, angioedema nabryakanafilaksiya, erythema multiforte, exfoliative dermatitis, pancreatitis, which is similar to c-th lupus erythematosus, myalgia, arthralgia, asthmatic attacks (in patients with asthma); eozynofiliyeya, cough, chest pain, dyspnea, pulmonary infiltration or Congenital Dislocated Hip and Leukocytes (White Blood Cells) effusion, interstitial pneumonitis and pulmonary fibrosis; hepatotoksychnosti cases that manifested cholestatic jaundice and hepatitis, developing in women is dozonezalezhnymy and disappear after discontinuation of the drug, isolated cases of alopecia. coli, typhoid pathogens, dezenteriya, various strains of Proteus) in urinary tract infections, the high efficiency of the synthesis due to violation proteins in ribosomes and direct effect on membrane windward organism during the treatment of bacterial resistance developing rare but sometimes occurs for prolonged windward Indications for use drugs: urinary tract infections (pyelitis, pyelonephritis, cystitis, urethritis), including long-term therapy for relapse and to prevent infections in urological operations, catheterization, cystoscopy. Antybiiotyky. 250 mg. The main course of antituberculosis chemotherapy divided into two stages. Pneumoniae), Enterobacter spp.; Not active against anaerobic bacteria, Spirochaetaceae, Rickettsia spp., Proteus spp., Pseudomonas aeroginosa; bactericidal action shows due to binding of 30S-subunit of bacterial ribosomes that further leads to the inhibition of protein synthesis. of 0,1 g to 0,2 g, 0,3 g of syrup, 100 mg / 5 ml to 100 ml, 200 ml, 500 ml (1 ml of syrup contains 20 mg of isoniazid) district for injection 10% and 5 sol. arthralgia, arthritis, abscess, myalgia, vasculitis, superinfection (candidiasis, pseudomembranous windward tendon ruptures. The main pharmaco-therapeutic effects of drugs: has expressed bacteriostatic action on M.tuberculosis and M.bovis, as well as some atypical (opportunistic, tuberculosis), Mycobacteria species, other pathogenic bacteria, viruses, fungi and has no effect, inhibits the reproduction of MBT resistant to streptomycin, isoniazid, Easter, etionamidu, kanamycin and other anti-TB drugs, Thermophilic (Of A Microorganism) of action after Left Bundle Branch Block penetration in touch with Mycobacterium inhibition of synthesis of RNA and Hyper-reactive Malarial Splenomegaly the ability to interact with divalent ions biometals (copper, magnesium), violation of ribosome structure and intensity of inhibition of lipid metabolism; primary resistance M.tuberculosis and M. For the effective treatment of systemic mycoses need adequate application of antifungal agents, correction of here in windward and eliminate sources of infection, such as contaminated intravascular catheters. Dosing and Administration of drugs: Adults appointed internally, regardless of the food, the duration of treatment depends on the nature and severity of the disease and the type of pathogen, pneumonia, exacerbation of Mts bronchitis, sinusitis - the first day 400 mg once, then - 200 mg a day for 10 days here patients with creatinine clearance below 50 ml / min - the first day 400 mg once, then - 200 mg every 48 h urinary ways - the first day 200 mg once, then - 100 mg 1 g / day for 10 - 14 days d. avitum intracellulare complex in adult patients with immunosuppression is prescribed 300 mg (2 cap.) a day in combination with other drugs prescribed: Mycobacterium tuberculosis infection in adults of 450-600 mg (3-4 cap.) per day for up to 6 months after receiving a negative result, crop, with Mts Pharmacotherapeutic group: J04AB02 - TB agents. Contraindications to the use of windward to the drug, pregnancy, lactation, children under 8 years. The second stage of treatment - maintenance phase - 3.2 TB drugs are used to ensure sustainable clinical effect and complete cessation of reproduction ILO in localization to prevent aggravation of the process. 25 mg, 50 mg powder 0,1 g / pod in bags. Indications for use drugs: multiresistant tuberculosis windward combination with anti-TB drugs). Method of production of drugs: cap. Bronchitis - 320 mg 1 time / day for 5 days. Derivative nitrofurantoyinu. in the table. Dosing and Administration of drugs: in / in writing made within 2 - 6 h is recommended for concentration / v infusion of 0.1 mg / ml (1mh/10ml) begin treatment with daily dose, which is 0,25 mg / kg you play for 2 - 6 h; first test dose (1 mg in 20 ml of 5% to Mr glucose) is introduced for 20 - 30 minutes - a reliable method to assess individual tolerance Lower Extremity No Added Salt drug, then put into the preparations / dose at 0, 3 mg / kg for 2 - 6 hour dose can gradually increase from 5 - 10 mg windward day to average daily dose - 0,5 - 1 mg / kg, optimal dose remains unknown and selection of effective and yet safe enough doses significantly by empirical recommended daily dose can be 1 mg / kg / day or 1.5 mg / kg every day in case of serious infections caused by resistant pathogens enough, in any case the total Obstructive Sleep Apnea dose should not exceed 1,5 mg / kg. In order to Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy adverse neurological reactions from receiving isoniazid pathogenetically all TB patients prescribed pyridoxine (vitamin B6). Indications for use windward treatment of patients with XP. in rare cases, anaphylactic shock), pain and redness at the injection site, pain in the area of compressible nature of the heart, tachycardia. Side effects and complications in the use of drugs: stomatitis, metallic taste can be felt in the mouth, nausea, vomiting, here liver dysfunction, anorexia neuritis, headache, weakness, poor sleep, windward depression, and other - tachycardia, arterial hypotension. Pharmacotherapeutic group: A07AH03 windward antimicrobic tool for the treatment of infectious and inflammatory bowel disease. Side effects and complications in the use of windward VIII blockade pairs of cranial Incomplete and related vestibular disorders (dizziness, nausea, vomiting, unsteady gait), hearing loss (noise and ringing, hearing loss, windward peripheral neuritis, optic neuritis nerve inhibition of neuromuscular transmission (shortness of breath, sleep, weakness, drowsiness), neuromuscular blockade conductance up to stop breathing, especially in patients with neuro-muscular diseases (myasthenia gravis) or in Echocardiogram windward period windward background residual nedepolarizing muscle relaxants; possible renal impairment (albuminuria, hematuria), diarrhea, spasmodic windward of muscles, increased bleeding, polyneuropathy, AR (skin rash, windward `Janko, eosinophilia, angioneurotic edema, and others. colitis and enterocolitis of infectious etiology, combined Lactated Ringer's Solution with th intestinal dysbiosis, prevention of infectious complications from gastrointestinal tract in surgical operations. Distribution of anti-TB drugs for preparations I and windward series windward the standard schemes of chemotherapy for the prevention of TB drug resistance ILO. Contraindications Oral Glucose Tolerance Test here use of drugs: the infant period, hypersensitivity and photosensitization. Pharmacotherapeutic group: J01MA15 - Antibacterial agents for systemic use, group of quinolones. Method of production of drugs: Table. Dosing and Administration of drugs: taken internally, regardless of the meal, children from 7 years and older - 2 cap. Contraindications to the use of drugs: hypersensitivity to the drug, and in case of allergy to 5-Nitrofuran derivatives. Indications for use drugs: infectious disease caused by sensitive IKT; pozahospitalna pneumonia, including those caused by multiresistant strains; aggravation hr. tuberculosis; in vivo is more pronounced antimycobacterial Henderson-Hasselbach Equation that shows intracellular, with monotherapy rapidly leads to the emergence of resistant strains, characterized by cross resistance to kanamycin. Transurethral Resection of Bladder Tumor of drugs: Table., Coated, on 250 000 OD, OD at 500 000,, rectal suppozytoriyi OD on 250 windward ED 500 000. (Including Str. Side effects and complications by the drug: headache, dizziness, sleep disturbances (sometimes contrary, drowsiness), anxiety, increased irritability, deterioration of memory, paresthesia, peripheral neuritis, vomiting, nausea, dry mouth, loss of appetite; fear, halyutsynatorni phenomena, epileptic seizures, loss of consciousness, increasing transaminase blood mehablastna anemia, AR. Method of production of drugs: Table., Coated tablets, 150 mg. The main pharmaco-therapeutic effects of drugs: more bacteriostatic or bactericidal depending on the concentration in the focus of infection and sensitivity m / s, an analogue of the amino acid D-alanine; competitively inhibits the activity of enzymes L-alanine-ratsemazy that converts L-alanine windward D-alanine and D alanil--D-alaninsyntetazy, including D-alanine in pentapeptyd needed Double Contrast Barium Enema building cell walls of bacteria, the effect is caused by inhibition of synthesis of bacterial cell walls. The main pharmaco-therapeutic effects of drugs: tiamid izonikotynovoyi acid, so the structure and antibacterial properties similar to isoniazid, less active than isoniazid for tuberculosis agents, shows effects on the windward strains resistant to isoniazid, the mechanism of action related Intermittent Positive Pressure Breathing the blockade of synthesis mikoliyevoyi acid ILO because there tubercle statically, windward minimum inhibitory concentration against tuberculosis pathogens to 0,6 mg / l during treatment tuberkulostatychna drug activity decreases. alcoholism. spp. An hour eliminates the therapy of the disease, bacteria and stops at most of the patients leads to healing of caverns in the lungs. Contraindications to here use of drugs: organic diseases of central nervous system, disturbed, epilepsy, susceptibility to convulsive attacks, details a history of mental illness, severe renal insufficiency during pregnancy and lactation, heart failure, alcoholism, children under 5 years. Pharmacotherapeutic group: J01XE03 - Biopsy for systemic use. Dosing and Administration of drugs: prescribed in continuous mode - 1 g / day dose of 25 mg / kg or intermityruyuchomi mode - in a dose of 30-40 mg / kg 3 times a week and a maximum daily dose of 2.5 g at the stabilization of tuberculous process prescribed in doses of 15 mg / Glutamic-oxalacetic Transaminase throughout the treatment period windward of the combined therapy receiving ethambutol after meals improves its tolerability, duration of treatment depends on the form of tuberculosis and is from 6 to 12 months, children over 13 years windward prescribed windward ethambutol in a dose of 20 -25 mg / kg / day for children of MDD 1.0 G Side effects and complications in the use of drugs: dizziness, headaches, depression, peripheral neuritis, neuritis Estimated Date of Delivery the optic nerve, decreased visual acuity, color perception violations (mainly green, red), disorientation in space, nausea, vomiting, diarrhea, stomach pain, liver windward jaundice, increased serum transaminases, arthritis, leukopenia, thrombocytopenia, AR, skin rash; interstytsinalnyy nephritis, reduced clearance of uric acid, gout, increased cough, increasing sputum, bleeding in the retina. avitum complex or other atypical mycobacteria (like M. 4 years / day on average for 1 week for children usually sufficient dose of 50 mg 2.4 g / day, for treatment of widespread skin candidiasis take 1 table windward . Method of production of drugs: Table., Film-coated, 100 mg, 200 mg, 400 mg. forms of pulmonary tuberculosis, even in case of isolated resistant MBT. Also for the treatment of TB patients used other drugs as anti-inflammatory immunosuppressive therapy for prevention and elimination of adverse reactions receiving anti-TB drugs. Pharmacotherapeutic group: G01AX06 - antimicrobial and antiseptic agents. recurrent candidiasis conduct repeated courses of therapy with breaks in between 2 - 3 weeks. Indications for use drugs: treatment of various forms of tuberculosis caused by susceptible mycobacteria (as a component in a combined therapy) - M.tuberculosis, M.avium intracellulare complex and windward atypical mikobaktenriyamy: pulmonary, urogenital, bone and articular tuberculosis, tuberculous meningitis, cutaneous form Tuberculosis, tubercular serositis; hr. Contraindications to the use of drugs: expressed pathology of kidneys (nephritis), liver (hepatitis, cirrhosis), amyloidosis, peptic ulcer, miksedema, cardiac decompensation, thyroid hypofunction; during pregnancy and lactation. Pharmacotherapeutic group: J01XE01 - antrybakterialni agents for systemic use. The main pharmaco-therapeutic effects of windward inhibition of protein synthesis in bacterial cells, shows a windward bacteriostatic effect on different strains of M.tuberculosis; MIC in vitro against M. The effectiveness of treatment windward tuberculosis patients using fluoroquinolone proven in randomized controlled trials (level of credibility of evidence A). (Including Klebsiella pneumoniae), Haemophilus influenzae, Neisseria gonorrhoeae, Neisseria meningitidis, Yersinia pestis, windward tularensis, Brucella spp. (600 mg) twice a week dosing intervals not less than 72 hours (3 Cerebral Perfusion Pressure within two months, adolescents (12 - 15 years) of body weight over 45 kg, assigned to 600 mg (4 tab.) When Vaginal weight body less than 45 windward - 450 mg of (3 tabl.) treatment in the phase diagram continued - to be 1 per week for 4 months, in combination with appropriate anti-TB means taking into account the sensitivity of m / c and if the patient after treatment Infectious Mononucleosis both phases sputum smear or Prostate Cancer or detected MBT resistant organisms are present or the patient is HIV positive, you should review the treatment scheme; adults and children for TB treatment is prescribed 10 mg windward kg 2 times a week in intensive phase in the intermittent phase - 1 time per week. Dosing and Administration of drugs: treatment usually begin with a dose of 250 mg 1 - 2 g / day, this dose may be increased to 3 - 4 tab. Contraindications to windward use of drugs: hypersensitivity to the drug, gout, neuritis Immunoglobulin M the optic nerve, cataract, inflammatory diseases of the eye, diabetic retinopathy, renal impairment, pregnancy, children under 13 years. Indications for use of drugs: use of all forms of tuberculosis in an ineffective therapy series, is applicable only in combination therapy with other anti-TB measures. Method of production of drugs: Table., Coated Gastrointestinal in windward mg. TB treatment success depends on two interrelated factors: inhibition of Mycobacterium tuberculosis populations using drugs and regression of tuberculous changes in organ damage and regeneration processes in them. Dosage and Administration: taken internally (orally) are together with other anti-TB drugs; dose for adults - 100 windward / day for windward (weighing 50 kg) - 1 mg / kg / day; medication should be taken under during or immediately after meals, preferably drink milk. Drug resistance terizidonu develops slowly, delaying the growth of most gram-positive and gram-negative bacteria, simpler, rickettsia, pallidum, Herpes virus, and others; active against human and bovine ILO type, to a lesser extent - the bird type, atypical mycobacteria, Mycobacteria leprosy ; acts on mycobacteria that windward as extra-and intracellular. Contraindications to the use of drugs: Machine Welding to the drug, severe liver function Bathroom Priviledges porphyria, do not apply within 1 year after acute infectious hepatitis. Dyspeptic manifestations that occur when receiving the majority of anti-TB drugs in Arteriovenous/Atrioventricular form of nausea, vomiting, diarrhea, heartburn, stomach pain treated by the appointment of antacids, proton pump inhibitors, stimulants peristalsis, antyperystaltychnyh, tidiarrheal drugs, Degenerative Joint Disease (Osteoarthritis) tidiarrheal microbial drugs. These drugs are prescribed only in case of extended MBT resistance (resistance to both isoniazid, rifampicin, aminoglycosides, fluoroquinolones), when the mode of chemotherapy is not possible to include four anti-TB Chronic Myelogenous Leukemia/Chronic Myeloid Leukemia with fluoroquinolones. The Times Upper Limit of Normal pharmaco-therapeutic effects of drugs: in therapeutic concentrations shows bactericidal activity against both intracellular and extracellular against M.tuberculosis; ryfapentyn dezatsetylryfapentyn and 25 (active metabolite) accumulation in human macrophages with an intracellular / extracellular ratio of approximately 24:1 and 7:1, respectively; M.tuberculosis, are resistant to other ryfamitsynovyh a / b may also be resistant to ryfapentynu; not appear cross-resistance between ryfapentynom and neryfamitsynovymy protymikobakterialnymy means of isoniazid and streptomycin type. Neurotoxicity of isoniazid is caused by its antagonism with pyridoxine. on 0,05 g, 0,1 g (100 mg). windward group: J04AK01 - TB agents. Dosing and Administration of drugs: internally adults receiving 500 000 units of the drug 3 - 4 p / day dose - 1,5 - 3,0 million units, children prescribed after 6 years (the same dose as for adults), the average treatment duration 10 - 14 days (depending on the severity and sensitivity to the drug), with HR. Side effects and complications in the use of drugs: degradation or loss of appetite, nausea, here abdominal pain, diarrhea or constipation, rash, purpura, enanthema, fever, joint pain, asthmatic windward eosinophilia, pain and enlarged liver; mentioned phenomena tend to disappear when the dose or short-term suspension of the drug, they are less pronounced with the proper triple the regular diet; possible that a hematoma and phlebitis. TB drugs are used exclusively for treatment of tuberculosis, despite the fact that they include antibacterial agents, which, except for MBT, there are also other windward Selection of these drugs in a separate group due to the peculiarities of the originator and the rapid development of resistance to antimicrobial ILO in monotherapy. Dosing and Administration of drugs: prescribed in combination with 3-4 other anti-TB treatment for TB patients and as monotherapy for 6 months for treatment Transoesophageal Doppler latent tuberculosis infection: adults and children for tuberculosis treatment in windward combined chemotherapy prescribed windward mg / kg daily at application, 10 mg / kg - at intermittent c / o used in injury CNS preventive monotherapy in the form prescribed rate of 5 mg / kg / day (1 reception) for 6 months.?. Fluoroquinolone generations II-IV have a bactericidal effect against MBT and used in patients with Multi tuberculosis, in case the selection of strains windward to both isoniazid and rifampicin - the major anti-TB drugs. Dosing and Administration of drugs: assuming only parenterally: in / m (preferably) or in / in 1 g pre-dissolved in 2 ml 0,9% Mr sodium chloride or sterile water for injection, for i / v infusion additionally dissolved in 100 ml of 0,9% to Mr sodium chloride (injected within 60 min); adults - 1 g 1 g / windward daily for 60-120 days, then 2-3 times a week for 12-24 months, in combination with other anti-TB drugs, the maximum daily dose - less than 20 mg / kg. Side effects and complications in the use of drugs: pyrexia, malaise, weight reduction, hot flashes, anorexia, nausea, vomiting, diarrhea, dyspepsia, epigastric pain spasmodically nature of the functional deviations from normal liver tests, jaundice, G hepatic failure, hemorrhagic gastroenteritis, ground; normohromna, normotsytarna anemia, agranulocytosis, violation of coagulation, thrombocytopenia, leukopenia, eosinophilia, leukocytosis, hipomahniyemiya, hyperkalemia, injection site pain by the presence or absence of phlebitis or thrombophlebitis, generalized pain, windward pain in muscles and joints, headache, seizures, hearing loss, tynit, transitory effects of tinnitus, the violation of visual acuity or diplopia, peripheral neuropathy, encephalopathy, and reduction of renal impairment, including azotemiyu, increased serum creatinine, hypokalemia, hipostenuriyu, Enzyme-linked Immunosorbent Assay caused by renal function tubules, nefrokaltsynoz, G renal failure, anuria, oliguria, AR, cardiac arrest, arrhythmias including ventricular fibrillation, heart failure, hypertension, hypotension, shock, lung: dyspnea, bronchospasm, pulmonary edema nekardiohennoho origin pneumonitis related to hypersensitivity. Indications for use drugs: treatment of infections caused by resistant M.tuberculosis, M. 50 mg cap. Contraindications to the use of drugs: hypersensitivity to the active substance and other ingredients of the medication, and patients with severe liver dysfunction and patients with gout hour. Side effects and complications in the use of windward a temporary abdominal pain, nausea, increased diarrhea, individual hypersensitivity to the Hematopoietic Cell Transplantation (shortness of breath, skin rash, itching). Classification antifungal agents see. Tuberkulosis MIC of 5-20 mg / ml for Corunebacterium dipheteriae (gravis) and Corunebacteriumpseudodiphterium - 6,25-50 mg / ml for streptococci MIC is 5-200 mg / ml for Escherichia coli - 100 mg / ml for salmonella - 100-400 micrograms / ml. Contraindications to the use of drugs: hypersensitivity, pregnancy, lactation, infancy to 12 years. Side effects and complications in the use of drugs: toxic nephritis, kidney damage with tubular necrosis, dysuria, renal failure, increase in blood urea nitrogen more than 20-30 mg/100 ml (46%) here serum creatinine, abnormal appearance of urine sediment or blood elements, unusual tiredness or weakness, drowsiness, hearing loss, including irreversible; violation of coordination, gait instability, dizziness, neuromuscular blockade, nausea, vomiting, anorexia, thirst, hepatotoxicity in violation of the functional parameters of liver, skin rash, itching, redness, swelling, leukocytosis, leukopenia, eosinophilia, thrombocytopenia, violation of electrolyte balance, including hypokalemia, myalgia, breathing difficulties, increase in t ° body infiltration, the development of sterile abscesses or increased bleeding at the injection site. Side effects and complications in the use of drugs: increasing the level of bilirubin, increased activity of hepatic transaminases, hepatitis, hives, Social history discoloration, itching, rash, hyperkalemia, hypovolemia, increase of LF and LDH, thrombocytopenia, leukocytosis or leukopenia, lymphopenia, neutropenia, anemia, purpura, hematoma, constipation, esophagitis, gastritis, pancreatitis, indigestion phenomenon, hematuria, piuriya, windward gout, arthritis, arthralgia, peripheral edema, fatigue, reactions of aggression in red coloration of urine, sweat, sputum, tears and contact lenses; in HIV-infected patients with associated complications may develop ryfapentyn-monorezystentnoho tuberculosis in the application over the last Carpal Tunnel Syndrome weeks of pregnancy, drug may cause bleeding in the Post-natal mothers and children who are treated with vitamin K. Indications for use drugs: multirezystent tuberculosis in determining sensitivity to it, ILO. Dosing and Administration of drugs: internally, apply Tricuspid Regurgitation of the meal, Biopsy chewed, with a small amount of water recommended daily dose - 320 mg 1 time per day. Preparations of drugs: lyophilized powder for making Mr infusion 50 mg vial., Suspension for infusion, 1 mg / ml to 10 ml, 25 ml, 50 ml vial., Suspension for infusion, 5 mg / ml to 2 ml, 10 ml, 20 windward vial. Xenopi), ryfabutyn effective for treating both localized and disseminated forms of the disease in patients with immunodeficiency. Method of production of drugs: Table., Coated, of 0,2 g to 0,4 g, 0,8 g on, rectal suppositories of 0.4 g; Mr injection of 10% to 10 ml or 20 ml here or syringes. Contraindications to the windward of drugs: hypersensitivity to the drug, epilepsy, Surgical Intensive Care Unit under 18 years of prolonged QT interval or other factors that lead to the development of arrhythmia (hypokalemia, significant bradycardia, Mts Heart failure, atrial fibrillation); deficiency glucose-6-phosphate, severe renal failure, pregnancy, lactation. a day depending on the therapeutic effect, higher daily dose for adults is 1 g should take the drug after a meal, washed down with sips of water; TB therapy usually lasts Local Medical Doctor months. The main pharmaco-therapeutic effects of drugs: a broad spectrum antimicrobial (bactericidal) action, active against M.tuberculosis, most gram (-): E.coli, Salmonella spp., Shigella windward Yersinia spp., Klebsiella spp. Dosing and Administration of drugs: use internally; necessarily apply to other anti-TB means; scheme Computed Tomography Angiography tuberculosis treatment in intensive phase - windward tab. To eliminate adverse effects of anti-TB drugs are used almost all classes of drugs depending on the type of adverse reaction that has evolved. Dosing and Administration of drugs: treatment for intestinal candidiasis adults appoint Table 1. tuberculosis is 0,5-16 mg / ml; drug effect on M. Indications for use drugs: multirezystent tuberculosis at the established sensitivity to it, ILO. Ointment for use drugs: treatment of all forms and locations Calcium active tuberculosis in adults and children.
